Strategy
Geographies
New York, NY
Portfolio
1 totalCo-Investors
4Latest Pulse
- Sep 3, 2026Crusoe Meets IPO Bankers Less Than a Year After $10BCrusoe has met with Goldman Sachs, Morgan Stanley, JPMorgan and Bank of America about a near-term IPO, the same week it reportedly closed a $3 billion round at $30 billion -- an unusually fast run from markup to public talks.→
- Aug 28, 2026Owner Raises $240M at $2.3B to Run Local BusinessesOwner, the AI platform that runs websites, ordering, marketing and phone support for restaurants, raised $240 million led by Growth Equity at Goldman Sachs Alternatives at a $2.3 billion valuation.→
- Aug 23, 2026Goldman Partner Warns of AI Eroding Bankers' ReasoningA Goldman Sachs partner has warned publicly that heavy reliance on AI tools risks eroding junior bankers' underlying reasoning and judgment skills, not just their task speed.→
- Aug 12, 2026Nvidia Is Turning AI Compute Into an Asset for Pension FundsNvidia has partnered with Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR on financing vehicles meant to mobilize more than $500 billion for AI infrastructure, routing pension and insurance capital into GPU-backed debt.→
- Aug 11, 2026Vaderis Raises $152M Series B for Rare Disease TrialVaderis Therapeutics closed an oversubscribed $152.5 million Series B co-led by Goldman Sachs Alternatives and TCGX to fund a global Phase 3 trial of its drug for a rare blood vessel disorder.→
- Aug 3, 2026Neoclouds Are Quietly Lining Up Behind SpaceX for IPOsNscale hiring Goldman Sachs and JPMorgan for a possible late-2026 IPO, on the heels of a $14.6 billion private valuation and a $1.65 billion Anyscale acquisition, is an early look at the neocloud sector's own path toward public markets.→
- Jul 30, 2026Neocloud Nscale Preps Investor Pitch for Multibillion IPOAI neocloud Nscale is getting ready to pitch investors on a multibillion-dollar IPO, having hired Goldman Sachs and JPMorgan after raising $2 billion at a $14.6 billion valuation earlier this year.→
- Jul 29, 2026Goldman-Backed Attovia Seeks $212.5M in Biotech IPOAttovia Therapeutics is seeking up to $212.5 million in a US IPO, offering 12.5 million shares at $15-$17 each, backed by Goldman Sachs Alternatives, Deep Track Capital, Frazier Life Sciences, and venBio.→
- Jul 28, 2026SK Hynix, Samsung Plunge, Dragging US Chip StocksSK Hynix fell 14.65% and Samsung dropped more than 13% in Seoul trading Tuesday, with Kioxia down over 18%, as Goldman Sachs warnings on HBM memory pricing dragged Micron, AMD and Intel lower in the US.→
- Jul 27, 2026Why 2026's IPO Market Already Beat Goldman's BetA Value Add Pulse analysis of 2026's IPO market finds proceeds already tracking well ahead of Goldman Sachs's February forecast of $160 billion for the full year, driven by a handful of enormous AI-adjacent listings.→